WATERTOWN, Mass.--(BUSINESS WIRE)--Wolfe Laboratories, Inc. (WLI), a biopharmaceutical development company, announces the creation of an Advisory Board. Comprised of individuals well known in the biopharmaceutical field, the new Advisory Board will provide WLI management with their expertise and consultation in several areas, including DMPK, manufacturing, and strategic planning.
